Schizophrenia Research
Volume 69, Issue 1 , Pages 55-65 , 1 July 2004

Olfactory identification and WAIS-R performance in deficit and nondeficit schizophrenia

  • Regine Anna Seckinger

      Affiliations

    • Corresponding Author InformationCorresponding author. New York State Psychiatric Institute, 1051 Riverside Drive, Box #2, New York, NY 10032, USA. Tel.: +1-212-543-6230; fax: +1-212-543-6176.
    • New York State Psychiatric Institute, Columbia University, New York, NY, USA
    • Department of Clinical Psychology, City University of New York, New York, NY, USA
    • ,
  • Nora Goudsmit

      Affiliations

    • New York State Psychiatric Institute, Columbia University, New York, NY, USA
    • ,
  • Eliza Coleman

      Affiliations

    • New York State Psychiatric Institute, Columbia University, New York, NY, USA
    • ,
  • Jill Harkavy-Friedman

      Affiliations

    • New York State Psychiatric Institute, Columbia University, New York, NY, USA
    • ,
  • Scott Yale

      Affiliations

    • New York State Psychiatric Institute, Columbia University, New York, NY, USA
    • ,
  • Paul J Rosenfield

      Affiliations

    • New York State Psychiatric Institute, Columbia University, New York, NY, USA
    • ,
  • Dolores Malaspina

      Affiliations

    • New York State Psychiatric Institute, Columbia University, New York, NY, USA

Received 12 November 2002 ,Revised 26 March 2003 ,Accepted 8 April 2003.

References 

  1. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986;9:357–381
  2. Alivisatos B, Petrides M. Functional activation of the human brain during mental rotation. Neuropsychologia. 1997;35:111–118
  3. Amsterdam JD, Settle G, Doty RL, Abelman E, Winokur A. Taste and smell perception in depression. Biol. Psychiatry. 1987;22:1477–1481
  4. Andreasen NC. Improvement of negative symptoms: concepts, definition and assessment. Int. Clin. Psychopharmacol. 1997;12S:S7–S10
  5. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. (Berl.). 1996;92:217–231
  6. Borod JC, Koff E, Perlman LM, Nicholas M. The expression and perception of facial emotion in brain-damaged patients. Neuropsychologica. 1986;24:169–180
  7. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia. Arch. Gen. Psychiatry. 1992;49:921–926
  8. Brewer WJ, Edwards J, Anderson V, Robinson T, Pantelis C. Neuropsychological, olfactory and hygiene deficits in men with negative symptom schizophrenia. Biol. Psychiatry. 1996;40:1021–1031
  9. Bryson G, Bell M, Kaplan E, Greig T, Lysaker P. Affect recognition in deficit syndrome schizophrenia. Psychiatry Res. 1998;77:113–120
  10. Bryson G, Whelahan HA, Bell M. Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Res. 2001;102:29–37
  11. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT. Clinical correlates of the deficit syndrome of schizophrenia. Am. J. Psychiatry. 1990;147:290–294
  12. Buchanan RW, Brier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, et al. Structural abnormalities in deficit and nondeficit schizophrenia. Am. J. Psychiatry. 1993;150:59–65
  13. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Brier A, Carpenter WT. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch. Gen. Psychiatry. 1994;51:804–811
  14. Buchsbaum MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr. Bull. 1990;16:379–389
  15. Buchsbaum MS, Awsare SV, Holcomb HH, DeLisi LE, Hazlett E, Carpenter WT, et al. Topographic differences between normals and schizophrenics: the N120 evoked potential component. Neuropsychobiology. 1986;15:1–6
  16. Carpenter WT, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry. 1988;145:578–583
  17. Carpenter WT, Lahti AC, Holcomb HH, Zhao M, Buchanan RW, Tamminga CA. Frontal and parietal blood flow activation during an auditory task differentiates schizophrenic patients with and without primary negative symptoms. Abstr. Soc. Neurosci. 1996;22:676
  18. Chase TN, Fedio P, Foster NL, Brooks R, Chiro GD, Mansi L. Wechsler adult intelligence scale performance: cortical localization by fluorodeoxyglucose F 18-Positron-emission tomography. Arch. Neurol. 1984;41:1244–1247
  19. Cleghorn JM, Garnet ES, Nahmias C, Firnau G, Brown GM, Kaplan R, et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res. 1989;28:119–133
  20. Cleghorn JM, Kaplan RD, Nahmias C, Garnett ES, Szechtman H, Szechtman B. Inferior parietal region implicated in neurocognitive impairment in schizophrenia. Arch. Gen. Psychiatry. 1989;46:758–760
  21. Coleman E, Goetz RR, Leitman D, Yale S, Stanford A, Gorman JM, et al. Odor identification impairments in schizophrenia: relationship with demographic measures, clinical variables, and diagnostic subtypes. CNS Spectr. 2002;7:43–48
  22. Corbetta M, Miezin FM, Dobmeyer S, Shulman GL, Petersen SE. Selective and divided attention during visual discrimination of shape, color, and speed: functional anatomy by positron emission tomography. J. Neurosci. 1991;11:2383–2402
  23. Cuesta MJ, Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res. 1995;58:227–235
  24. Cummings JL. Frontal–subcortical circuits and human behavior. Br. J. Psychiatry. 1993;161(50):873–880
  25. Cutting J. Delusional misidentification and the role of the right hemisphere in the appreciation of identity. Br. J. Psychiatry Suppl. 1991;14:70–75
  26. Damasio RA. Disorders of complex visual processing: agnosias, achromatopsia, Balint's syndrome, and related difficulties of orientation and construction. In:  Mesulam M-M editors. Principles of Behavioral Neurology. Philadelphia: Davis; 1988;p. 259–288
  27. Doty RL. The Smell Identification Test Administration Manual. 3rd ed.. Haddon Heights, NJ: Sensonics; 1984;
  28. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function. Physiol. Behav. (Monogr.). 1984;32:489–502
  29. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38:1237–1244
  30. Doty RL, Smith R, McKeown DA, Raj J. Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance. Percept. Psychophys. 1994;56:701–707
  31. Duvernoy HM. The human brain surface. In: Three-Dimensional Sectional Anatomy and MRI. Wien: Springer-Verlag; 1998;p. 10–11
  32. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry. 1976;33:766–771
  33. Erwin BJ, Rosenbaum G. Parietal lobe syndrome and schizophrenia: comparison of neuropsychological deficits. J. Abnorm. Psychology. 1979;88:234–241
  34. Fenton WS, McGlashan TH. Antecedents, symptom progression and long-term outcome of the deficit syndrome in schizophrenia. Am. J. Psychiatry. 1994;153:351–356
  35. Frederikse M, Lu A, Aylward E, Barta P, Sharma T, Pearlson G. Sex differences in inferior parietal lobule volume in schizophrenia. Am. J. Psychiatry. 2000;157:422–427
  36. Fried I, Mateer C, Ojemann G, Wohns R, Fedio P. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J. Clin. Exp. Neuropsychol. 1982;9:180–186
  37. Galderisi S, Mj M, Mucci A, Cassana GB, Invernizzi G, Rossi A, et al. Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am. J. Psychiatry. 2002;156:983–990
  38. Goldman-Rakic PS. Working memory systems in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 1994;6:348–357
  39. Harvey I, Ron MA, duBoulay G, Wicks D, Lewis SW. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol. Med. 1993;23:591–604
  40. Hemdal P, Corwin J, Oster H. Olfactory identification deficits in Down's syndrome and idiopathic mental retardation. Neuropsychologia. 1993;31:977–984
  41. Hurwitz T, Kopala L, Clark C, Jones B. Olfactory deficits in schizophrenia. Biol. Psychiatry. 1988;23:123–128
  42. Kaufman AS. Assessing Adolescent and Adult Intelligence. Boston: Simon & Schuster; 1990;
  43. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  44. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30:119–123
  45. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res. 1993;47:47–56
  46. Kirkpatrick B, Ram R, Bromet EJ. The deficit syndrome in the Suffolk Country mental health project. Schizophr. Res. 1996;22:119–126
  47. Kirkpatrick B, Amador XF, Flaum M, Yale SA, Gorman JM, Carpenter WT, et al. The deficit syndrome in the DSM-IV field trial: I. Alcohol and other drug abuse. Schizophr. Res. 1996;20:69–77
  48. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry. 2001;58:165–170
  49. Kopala LC, Clark C, Hurwitz TA. Sex differences in olfactory function in schizophrenia. Am. J. Psychiatry. 1989;146:1320–1322
  50. Kopala LC, Good K, Honer WG. Olfactory identification ability in pre- and postmenopausal women with schizophrenia. Biol. Psychiatry. 1995;38:57–63
  51. Lacquaniti F, Perani D, Guigon E, Bettinardi V, Carrozzo M, Grassi F, et al. Visuomotor transformations for reaching to memorized targets: a PET study. Neuroimage. 1997;5:129–146
  52. Lenzenweger MF. Two-point discrimination thresholds and schizotypy: illuminating a somatosensory dysfunction. Schizophrenia. 2000;42:111–124
  53. Levin S. Frontal lobe dysfunction in schizophrenia: I. Eye movement impairments. J. Psychiatr. Res. 1984;18:27–55
  54. Levin S. Frontal lobe dysfunction in schizophrenia: II. Impairments of psychological and brain functions. J. Psychiatr. Res. 1984;18:57–72
  55. Liddle PF. Syndromes in schizophrenia and their neuropsychological and neuroanatomical correlates. In:  Pantelis C,  Nelson HE,  Barnes TRE editor. Schizophrenia: A Neuropsychogical Perspective. Chichester, UK: Wiley; 1996;p. 299–313
  56. Malaspina D, Coleman E. Olfaction and social drive in schizophrenia. Arch. Gen. Psychiatry. 2003;60:578–584
  57. Malaspina D, Wray AD, Friedman JH, Amador X, Yale S, Hasan A, et al. Odor discrimination deficits in schizophrenia: associations with eye movement dysfunction. J. Neuropsychiatry Clin. Neurosci. 1994;6:273–278
  58. Malaspina D, Perera GM, Lignelli A, Marshall RS, Esser PD, Storer S, et al. SPECT imaging of odor identification in schizophrenia. Psychiatry Res. 1998;82:53–61
  59. Malaspina D, Bruder G, Furman V, Gorman JM, Berman A, Van Heertum R. Schizophrenia subgroups differing in dichotic listening laterality also differ in neurometabolism and symptomatology. J. Neuropsychiatry Clinical Neurosci. 2000;12(4):485–492
  60. Malaspina D, Coleman E, Goetz RR, Harkavy-Friedman J, Corcoran C, Amador X, et al. Odor identification, eye tracking, and deficit syndrome schizophrenia. Biol. Psychiatry. 2002;51:809–815
  61. Martzke JS, Kopala LC, Good KP. Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol. Psychiatry. 1997;42:721–732
  62. McFie J. Psychological testing in clinical neurology. J. Nerv. Ment. Dis. 1960;131:383–393
  63. Mesulam MM. From sensation to cognition. Brain. 1998;121:1013–1052
  64. Mesulam MM, Geschwind N. On the possible role of neocortex and its limbic connections in the process of attention and schizophrenia. J. Psychiatric Res. 1978;14:249–259
  65. Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI, Doty RL. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology. 1999;21:25–340
  66. Nkam I, Thibaut F, Denise P, Van Der Elst A, Ségard L, Brazo P, et al. Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia. Schizophr. Res. 2001;48:145–153
  67. Norman RM, Malla AK, Morrison-Stewart SL, Helmes E, Williamson PC, Thomas J, et al. Neuropsychological correlates of syndromes in schizophrenia. Br. J. Psychiatry. 1997;170:134–139
  68. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SC, Harkavy-Friedman J, et al. Diagnostic interview for genetic studies: rationale, unique features, and training: NIMH genetics initiative. Arch. Gen. Psychiatry. 1994;51:849–859
  69. O'Leary DS, Flaum M, Kesler ML, Flashman L, Arndt S, Andreasen NC. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J. Neuropsychiatry Clin. Neurosci. 2000;12:4–15
  70. Pantelis C, Brewer W. Neuropsychological and olfactory dysfunction in schizophrenia: relationship of frontal syndromes to syndromes of schizophrenia. Schizophr. Res. 1995;17:35–45
  71. Pearlson GD, Petty RG, Ross CA, Tien YA. Schizophrenia: a disease of the heteromodal association cortex?. Neuropsychopharmacology. 1996;14:1–17
  72. Pierrot-Deseilligny C, Rivaud S, Gaymard B, Agid Y. Cortical control of reflexive visually-guided saccades. Brain. 1991;1473–1485
  73. Pogue-Geile MF, Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr. Bull. 1985;11:427–439
  74. Purdon SE. Olfactory identification and Stroop interference converge in schizophrenia. J. Psychiatry Neurosci. 1998;23:163–171
  75. Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, et al.  Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients. Am. J. Psychiatry. 1996;153:1158–1165
  76. Ross DE, Thaker GK, Buchanan RW, Kirkpatrick B, Lahti AC, Medoff D, et al.  Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome. Biol. Psychiatry. 1997;42:781–796
  77. Rossi A, Stratta P, D'Albenzio L, diMichele V, et al.  Quantitative computed tomographic study in schizophrenia: cerebral density and ventricular measures. Psychol. Med. 1989;109:337–342
  78. Russel EW. Three patterns of brain damage on the WAIS. J. Clin. Psychol. 1979;35:611–620
  79. Schroeder J, Buchsbaum MS, Siegel BV, Geider FJ, Haier RJ, Lohr J, et al. Patterns of cortical activity in schizophrenia. Psychol. Med. 1994;24:947–955
  80. Seidman LJ, Talbot NL, Kalinowski AG, McCarley RW, Faraone SV, Kremen AA, et al. Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia: olfactory identification and Wisconsin Card Sorting performance. Schizophr. Res. 1992;6:55–65
  81. Seidman LJ, Goldstein JM, Goodman JM, Koren D, Turner WM, Faraone SV, et al. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relation to attention and verbal ability. Biol. Psychiatry. 1997;42:104–115
  82. Serby M, Larson P, Kalkstein D. Olfactory sense in psychoses: letter to the editor. Biol. Psychiatry. 1990;28:829–830
  83. Simpson CD, Vega A. Unilateral brain damage and patterns of age-corrected WAIS subtest scores. J. Clin. Psychol. 1971;27:204–208
  84. Smith A. Certain hypothesized hemispheric differences in language and visual functions in human adults. Cortex. 1966;2:109–126
  85. Stedman TJ, Clair AL. Neuropsychological, neurological and symptom correlates of impaired olfactory identification in schizophrenia. Schizophr. Res. 1998;32:23–30
  86. Tamminga CA, Thaker GK, Buchanan RW, Kirkpatrick B, Alphs LD, Carpenter WT, et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeosyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry. 1992;49:522–530
  87. Tamminga CA, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int. Clin. Psychopharmacology. 1998;13S:S21–S26
  88. Thaker G, Kirkpatrick B, Buchanan RW, Ellsberry R, Lahti A, Tamminga CA. Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychopharmacol. Bull. 1989;25:491–498
  89. Todd J, Coolidge F, Satz P. The Wechsler Adult Intelligence Scale discrepancy index: a neuropsychological evaluation. J. Consult. Clin. Psychol. 1977;45:450–454
  90. Uzzell BP, Zimmerman RA, Dolinskas CA, Obrist WD. Lateralized psychological impairment associated with CT lesions in head injured patients. Cortex. 1979;15:391–401
  91. Vega A, Parsons OA. Relationship between sensory-motor deficits and WAIS verbal and performance scores in unilateral brain damage. Cortex. 1969;5:229–241
  92. Wagman AMI, Heinrichs DW, Carpenter WT. Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation. Psychiatry Res. 1987;22:319–330
  93. Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR. Olfactory deficits and Alzheimer's disease. Biol. Psychiatry. 1986;21:116–118
  94. Wechsler D. Wechsler Adult Intelligence Scale-Revised. Manual. New York: Psychological; 1981;
  95. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 1987;44:660–669

PII: S0920-9964(03)00124-5

doi: 10.1016/S0920-9964(03)00124-5

Schizophrenia Research
Volume 69, Issue 1 , Pages 55-65 , 1 July 2004

Article Tools